14 results
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Agents for COVID ... 4/11/2020 #Drugs ... #COVID19 #Pharmacology ... #Table #Management ... #MGH
Vancomycin Associated Acute Kidney Injury

 • Drug induced acute kidney injury is generally defined as a
Kidney Injury • Drug ... • Treatment includes ... #Vancomycin #AKI ... #pharmacology # ... toxicology #diagnosis #management
Rhabdomyolysis - Differential Diagnosis and Management Summary

Trauma:
 • Immobilization, Crush iniury, Compartment syndrome, Electrical injury
Exertional:
 •
Diagnosis and Management ... Drugs (Statins), ... Dermatomyositis) AKI ... - Pathophysiology ... per day until stable
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
mucoadhesive buccal tablet ... chew, or crush tablet ... for effective treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology
Rhabdomyolysis - Differential Diagnosis Framework and Management Summary

Causes of Rhabdomyolysis:
 • Trauma:
	- Immobilization
	- Crush injury
	- Compartment
Framework and Management ... - Toxins - Drugs ... declines > ALT) • AKI ... + myoglobin AKI ... if levels > 8 mg
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
please refer to Table ... (AI) when drug ... IDSA #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology
Hemophagocytic Lymphohistiocytosis (HLH)
Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
Lymphohistiocytosis (HLH) Pathophysiology ... immune deficiency, Drugs ... of emergency, ICU ... Lymphohistiocytosis #diagnosis #management ... #treatment #summary
Pain, Agitation, and Delirium (PAD) in the ICU
Addressing the ICU Triad (PAD) can be accomplished through
A dissociative drug ... doses (ie. 20 mg ... non-OTC prolonging agent ... No pharmacologic ... CriticalCare #diagnosis #management
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
Immunosuppressive agents ... Etiology: • Pathophysiology ... abnormality, Medication/Drug ... level (mean 58 mg ... Syndrome #diagnosis #management
Potential Treatment Agents for Treatment of the Primary Clostridium difficile infection Episode
Proven efficacy:
 • Vancomycin -
Potential Treatment ... Agents for Treatment ... ClostridiumDifficile #options #treatment ... #management #pharmacology ... #idsa #table